News & Discoveries

June 28, 2023

Scientists discover a genetic clue to why some people with MS become disabled faster than others. A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.

June 20, 2023

US News & World Report lists UCSF Benioff Hospitals among best for kids in all 10 specialties. UCSF Benioff Children’s Hospitals are recognized among the nation’s best pediatric medical centers in all 10 specialties assessed in U.S. News & World Report’s Best Children’s Hospitals 2023-24.

June 15, 2023

Will you want one? The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.

June 15, 2023

A new treatment approach draws on research into the unique teenage brain. A new treatment approach draws on research into the unique teenage brain.

June 12, 2023

UCSF-led research identifies hallmark of disease repair for use in future therapies UCSF researchers developed an approach to measure an over-the-counter allergy medication’s effectiveness in repairing brain damage from multiple sclerosis (MS), making it possible to also assess future therapies for the disorder.

May 30, 2023

UCSF scientists show how the anti-seizure medication, gabapentin, interacts with ion channels. UCSF researchers discover how gabapentin interacts with calcium channels, opening doors for more effective treatments in epilepsy and Lupus by influencing channel biogenesis.

May 22, 2023

In a First, UCSF Researchers Have Identified Chronic Pain States in Individuals Directly from Their Neural Activity In a first, researchers have identified chronic pain pathways in individuals directly from their neural activity, showing promising paths forward for treatment.

May 15, 2023

Symptoms Take Decades to Develop, UCSF-SFVA Led Study Shows Exposure to trichloroethylene (TCE), a chemical found in the air, water, and soil, may increase the risk of Parkinson's disease by 70%, according to a UCSF study. TCE is commonly used today as a degreasing solvent.

May 15, 2023

Saul Villeda Delivers 2023 Byers Award Lecture on Reversing Aging’s Effects on the Brain Saul Villeda, the 2023 recipient of the Byers Award, delivered a lecture titled "Blood Work and the Brain: Deciphering the Language of Cognitive Rejuvenation." His research focuses on understanding the biological mechanisms behind cognitive decline with age and exploring potential ways to reverse it.

May 10, 2023

Common and Cheap Epilepsy Drug Stops Tumor Growth in Mice UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.